Mercer Global Advisors
RDY icon

Mercer Global Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Mercer Global Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
25,055
+6,857
+38% +$92.5K ﹤0.01% 2608
2026
Q1 		$252K Sell
18,198
-1,537
-8% -$21.4K ﹤0.01% 2611
2025
Q4 		$277K Sell
19,735
-3,612
-15% -$50.7K ﹤0.01% 2301
2025
Q3 		$326K Sell
23,347
-1,824
-7% -$26.2K ﹤0.01% 2028
2025
Q2 		$378K Sell
25,171
-637
-2% -$9.1K ﹤0.01% 1717
2025
Q1 		$340K Sell
25,808
-1,611
-6% -$22.2K ﹤0.01% 1691
2024
Q4 		$433K Sell
27,419
-105,521
-79% -$1.59M ﹤0.01% 1528
2024
Q3 		$424K Buy
132,940
+108,215
+438% +$1.74M ﹤0.01% 1426
2024
Q2 		$377K Buy
24,725
+1,580
+7% +$22.6K ﹤0.01% 1461
2024
Q1 		$335K Sell
23,145
-5,770
-20% -$84.2K ﹤0.01% 1502
2023
Q4 		$402K Buy
28,915
+11,585
+67% +$155K ﹤0.01% 1451
2023
Q3 		$232K Sell
17,330
-445
-3% -$6.02K ﹤0.01% 1688
2023
Q2 		$224K Buy
+17,775
New +$207K ﹤0.01% 1677
2022
Q3 		– Sell
-18,835
Closed -$209K – 1897
2022
Q2 		$209K Sell
18,835
-1,500
-7% -$16.3K ﹤0.01% 1618
2022
Q1 		$227K Sell
20,335
-2,420
-11% -$27.4K ﹤0.01% 1656
2021
Q4 		$298K Sell
22,755
-1,240
-5% -$15.6K ﹤0.01% 1470
2021
Q3 		$313K Sell
23,995
-5,160
-18% -$68.8K ﹤0.01% 1411
2021
Q2 		$429K Buy
29,155
+3,050
+12% +$42.7K ﹤0.01% 1214
2021
Q1 		$321K Buy
26,105
+2,780
+12% +$35.7K ﹤0.01% 1279
2020
Q4 		$333K Buy
23,325
+5,545
+31% +$74.7K ﹤0.01% 1032
2020
Q3 		$247K Buy
+17,780
New +$212K ﹤0.01% 1037

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Mercer Global Advisors's RDY Position: Q2 2026 in Review

Mercer Global Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 38% in Q2 2026, buying an estimated $92.5K and bringing the position to 25,055 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Mercer Global Advisors first reported a position in RDY in Q3 2020 and has held it in 21 quarters since. The position peaked at $433K in Q4 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Mercer Global Advisors held 25,055 shares of Dr. Reddy's Laboratories worth $363K as of Q2 2026.
  • Mercer Global Advisors bought 6,857 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $92.5K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2608 holding.
  • Mercer Global Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2020 and has held it in 21 quarters since.
  • Mercer Global Advisors's Dr. Reddy's Laboratories position peaked at $433K in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.